Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Actelion Looks To Open Up Secondary Markets For Tracleer

Aug. 21, 2002

By Cormac Sheridan

Cureon Raises DKK34M For Antisense DNA Analogue

Aug. 14, 2002

By Cormac Sheridan

Cureon Raises DKK34M For Antisense DNA Analogue

Aug. 14, 2002

By Cormac Sheridan

Elan Selling Off Assets, Cutting Employees In Restructuring Plan

Aug. 7, 2002

By Cormac Sheridan

Elan Selling Off Assets, Cutting Employees In Restructuring Plan

Aug. 7, 2002

By Cormac Sheridan

Genmab Pulling Listing From Germany's Troubled Neuer Markt

July 31, 2002

By Cormac Sheridan

Genmab Pulling Listing From Germany's Troubled Neuer Markt

July 31, 2002

By Cormac Sheridan

Stem Cell Research Center To Push Science In Denmark

July 24, 2002

By Cormac Sheridan

Stem Cell Research Center To Push Science In Denmark

July 24, 2002

By Cormac Sheridan

Swiss Start-Up Addex Raises CHF15.75M To Treat Addiction

July 17, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...